REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs | MicrobiomeTrials← Back to trialsNCT05622721
REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
RecruitingOBSERVATIONAL
Trial Details
Start: 2022-05-30Est. Completion: 2026-09-01
Enrollment target: 200 participants Locations- The Robert Schattner Center, University of Pennsylvania, School of Dental Medicine, Philadelphia, Pennsylvania, United States
Other microbiome trials you might be interested in
Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS), characterized by the Rome IV criteria, is a functional bowel disorder combining abdomina…
Lyon, FranceEst. completion Oct 10, 2028
Intestinal Disease
The gut microbiota plays a crucial role in human health, influencing metabolism, immunity, and pathogen resistance. Rese…
Rome, ItalyEst. completion Mar 10, 2027
This study aims to determine the effect of three factors (delivery type, feeding type and the use of two different dieta…
Sant Cugat del Vallès, SpainCompleted Mar 12, 2024